A naturally occurring enzyme may reduce inflammation and reduce pain without the risk of addiction, according to new research.
Selective molecules that inhibit DAGL-β are similar to non-steroidal anti-inflammatory drugs, said Ken Hsu, Ph.D., a chemistry professor at the University of Virginia. But they work without gastrointestinal toxicity common in NSAIDs, and without the addictive properties of opioids.
“We’re suggesting a different approach, one where we can stop inflammation without impacting the normal immune response,” he said in Cell Chemical Biology.
From the June 6, 2019 Issue of McKnight's Long-Term Care News
